Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


The Effect of N2O on Chronic Neuropathic Pain


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02246517

Organisation Name: Tel-Aviv Sourasky Medical Center

Overal Status: Unknown status

Start Date: September 2014

Last Update: September 22, 2014

Lead Sponsor: Tel-Aviv Sourasky Medical Center

Brief Summary: Important pharmacological agents for treatment of chronic neuropathic pain such as ketamine block NMDA receptors. Nitrous oxide, an inhalant agent used extensively In anesthesia, also have antagonist property of NMDA receptors. The investigators hypothesize that prolonged treatment with N2O can alleviate chronic neuropathic pain of different causes (e.g. diabetic neuropathy, post herpetic neuralgia etc.).

Conditions:
  • Neuropathic Pain


Total execution time in seconds: 0.20903301239014